Barclays’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,568
Closed -$175K 5369
2022
Q1
$175K Sell
1,568
-2,981
-66% -$372K ﹤0.01% 3504
2021
Q4
$754K Buy
4,549
+2,176
+92% +$377K ﹤0.01% 2995
2021
Q3
$422K Buy
2,373
+1,142
+93% +$232K ﹤0.01% 3273
2021
Q2
$233K Sell
1,231
-8,121
-87% -$1.38M ﹤0.01% 3479
2021
Q1
$1.8M Buy
9,352
+995
+12% +$231K ﹤0.01% 2373
2020
Q4
$1.8M Sell
8,357
-506
-6% -$113K ﹤0.01% 2312
2020
Q3
$2.06M Sell
8,863
-994
-10% -$286K ﹤0.01% 2076
2020
Q2
$3.23M Buy
9,857
+6,010
+156% +$1.27M ﹤0.01% 1711
2020
Q1
$579K Buy
3,847
+995
+35% +$89.8K ﹤0.01% 3473
2019
Q4
$278K Buy
2,852
+972
+52% +$82K ﹤0.01% 4779
2019
Q3
$142K Buy
1,880
+1,500
+395% +$174K ﹤0.01% 5212
2019
Q2
$70K Sell
380
-1,192
-76% -$176K ﹤0.01% 5928
2019
Q1
$247K Buy
1,572
+682
+77% +$97.9K ﹤0.01% 4666
2018
Q4
$142K Buy
+890
New +$128K ﹤0.01% 4815

Other funds holding VAPO

Barclays's VAPO Position: Q2 2022 in Review

Barclays sold out of Vapotherm, Inc. Common Stock (VAPO) in Q2 2022, closing a stake of 1,568 shares — an estimated $175K sold.

Barclays first reported a position in VAPO in Q4 2018 and held it in 14 quarters. The position peaked at $3.23M in Q2 2020. 77 funds tracked by Wall St. Rank hold VAPO as of Q2 2022.

  • Barclays reported no remaining Vapotherm, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 1,568 Vapotherm, Inc. Common Stock shares in Q2 2022, an estimated $175K.
  • Barclays first reported a position in Vapotherm, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Barclays's Vapotherm, Inc. Common Stock position peaked at $3.23M in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.